Frederik Pagh Kristensen
@pagh_kristensen
Followers
136
Following
1K
Media
16
Statuses
83
MD & PhD student at @dceaarhus | Main interests: diabetes and related macro- and microvascular complications. Son of a potato farmer. Sports enthusiast
Aarhus
Joined July 2021
The poster session is on at #ISPEANNUAL2024 π₯. Drop by poster no. 36 if you are interested in socioeconomic position and diabetes π @DCEAarhus
#DCEatICPE
0
0
17
Awesome team of experts ready to tell about applied sensitivity analyses at #ISPEAnnual2024 π€© @DCEAarhus
#DCEatICPE
0
1
17
All packed and ready for the #ISPEAnnual2024 in Berlin next week π The @DCEAarhus team will be presenting a whopping 22 posters and 6 orals π€© Check out our scientific contributions here: https://t.co/DZZEB3lr5c
#DCEatICPE
@IntPharmacoEpi @AarhusUni_int @AUHdk
0
2
17
Current projections estimate 153 million people will be living with dementia by 2050. Nearly half of dementia cases could be prevented or delayed by tackling 14 risk factors starting in childhood, suggests new report from a standing Lancet Commission: https://t.co/ZFRBBbIfdZ
53
859
1K
π¨Proud to share our latest findings in @greenjournal. Among several lipid parameters, high triglycerides are a strong risk factor for DPN in two T2D cohorts. Our study suggests targeting triglycerides may be crucial in DPN prevention. If interested:π @DCEAarhus @AarhusUni_int
1
2
11
My letter in the Times has generated a lot of interest so I thought it might help if I described the time line for reaching this frame of mind. I attach a copy of the letter and then run through a series of tweets to tell the story.
8
52
129
Neurological conditions now leading cause of ill health and disability globally, affecting 3.4 billion people worldwide, suggests GBD study in @TheLancetNeuro π https://t.co/bEuxuX0FKm
7
285
427
NEW PAPER out in @bmj_latest (led by @ConnerGanjavi and @Cacciamani_MD) showing the variability in publisher and journal instructions to authors on using #GenerativeAI in academic & scientific publishing -> https://t.co/vMh0DnmuMN
#AcademicTwitter #scientificpublishing #AI #LLMs
1
26
58
All 3 papers (#openaccess) now out in the @bmj_latest on the **Evaluation of clinical prediction models** part 1: https://t.co/vzcu6CXPCi part 2: https://t.co/TXPfMLmi1r part 3: https://t.co/yZ0J1VYp6d
#stats #MachineLearning #predictiveanalytics
5
182
463
Why Stating Hypotheses in Grant Applications Is Unnecessary @JAMA_current @_MiguelHernan @Lester_Domes
3
26
89
We have just completed & published a large set of 8 focussed reviews looking at the design/methods, reporting, risk of bias and spin/overinterpretation of #machinelearning based prediction model studies in healthcare. The findings donβt paint a good picture. A little summary π§΅
17
209
541
45% of all deaths in Europe are attributed to cardiovascular diseases! In our October Issue, we dive into tackling CVD in Europe with a π§ππ° πππ«π’ππ¬ (of 4 papers) on 'Variations in cardiovascular disease outcomes across Europe' π https://t.co/ZM7u3LsE82
3
23
47
A great honor presenting my latest study about lipid parameters and risk diabetic neuropathy in T2D at the #EASD2023. Thx to @dr_rwt, @ToftSorensen, @DianaCh88105662, & @CallaghanNeuro for unlimited support! @DCEAarhus @AarhusUni_int
1
3
31
Great talk by @ChristianStevns about epidemiology of diabetic neuropathy! ππ Longitudinal studies are needed to improve prevention! #EASD2023 @Stenodiabetes @DCEAarhus
2
1
11
Our colleagues are en route to #EASD2023 in Hamburg, ready for a week full of #diabetes research π€© @DCEAarhus has contributed to a total of 9 oral/short oral presentations. See you all in Hamburg! @EASDnews, @HealthAarhusUni, @AarhusUni_int, @AUHdk
0
2
27
For all the details & insights dive into our published study in Diabetes Care. https://t.co/oXi5nV1muA Thank you @JakobTarp, @Ulf_Ekelund, @knuteirik47, @adrianosanlas, @BorjadelPozoCr1, @RiedMathias, @DrMelodyDing, and @dr_rwt for a fruitfull collaboration on this project!
diabetesjournals.org
OBJECTIVE. The aim of this study was to determine dose-response associations, including the minimal effective level, between leisure-time physical activity
0
0
5
π Our research bridges an important gap, providing a quantitative target for leisure-time physical activity to prevent microvascular complications in type 2 diabetes. Exciting times ahead for evidence-based clinical recommendations! ππ¬#EvidenceBasedMedicine
1
0
2
π Fascinatingly, we found that the minimal effective physical activity level, for both neuropathy and nephropathy prevention, could be as simple as less than 1.5 hours of walking per week. Small changes, big impact! πΆββοΈβ° #PhysicalActivityThreshold
1
0
2